Ceritinib Impurity 7 | CAS 112108-73-3 - Request Quote
Ceritinib Impurity 7
| SZ CAT No: | SZ-C136008 |
| CAS No | 112108-73-3 |
| Mol.F. | C7H5ClFNO2 |
| Mol.Wt. | 189.6 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Ceritinib Impurity 7 is chemically 1-Chloro-5-fluoro-2-methyl-4-nitrobenzene. Ceritinib Impurity 7 is supplied with detailed characterization data compliant with regulatory guideline. Ceritinib Impurity 7 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ceritinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 112108-73-3
Purchase 112108-73-3
Order 112108-73-3
Enquire 112108-73-3
price of 112108-73-3
112108-73-3 Supplier
112108-73-3 Manufacturer
112108-73-3 Exporter
buy high quality Ceritinib Impurity 7
Purchase Ceritinib Impurity 7
Ceritinib Impurity 7 suppliers
Ceritinib Impurity 7 manufacturers
Ceritinib Impurity 7 price
Order Ceritinib Impurity 7
Enquire Ceritinib Impurity 7
Ceritinib Impurity 7 cost
Ceritinib Impurity 7 Supplier
Ceritinib Impurity 7 Distributor
Ceritinib Impurity 7 for Method Validation
Ceritinib Reference Standard
Ceritinib Impurity 7 for ANDA Filing
Ceritinib Impurity 7 for Forced Degradation Studies
Ceritinib Impurity 7 Identification Standards
Ceritinib Impurity 7 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


